Single amino acid change in Tat determines the different rates of replication of two sequential HIV-1 isolates
- PMID: 8337822
- DOI: 10.1006/viro.1993.1394
Single amino acid change in Tat determines the different rates of replication of two sequential HIV-1 isolates
Abstract
Human immunodeficiency virus type 1 (HIV-1) isolates display differences in their patterns of replication in vitro. Previous studies with recombinant viruses generated between two sequential HIV-1 isolates that differ in replication rates have shown that the determinant for this biological property maps to a region of the viral genome that encompasses the tat gene. In the present study, we examined if there is a functional difference in the Tat protein of the two isolates. We observed that the level of transactivation induced by Tat of the fast replicating, highly cytopathic virus (HIV-1SF13mc) was three- to eightfold higher than the level seen by the Tat of the slow replicating virus (HIV-1SF2mc). Furthermore, a single amino acid mutation in the HIV-1SF13mc. Tat leads to reduced transactivation activity of the mutant protein and a delayed replication rate of the mutant virus. Thus, selection of a Tat variant with higher transactivation potential could be responsible for the increased virus production that is often associated with a pathogenic HIV strain.
Similar articles
-
Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.J Virol. 2000 Mar;74(6):2703-13. doi: 10.1128/jvi.74.6.2703-2713.2000. J Virol. 2000. PMID: 10684286 Free PMC article.
-
Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.Virology. 1995 Aug 1;211(1):157-69. doi: 10.1006/viro.1995.1388. Virology. 1995. PMID: 7645208
-
Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.J Virol. 1991 Dec;65(12):6931-41. doi: 10.1128/JVI.65.12.6931-6941.1991. J Virol. 1991. PMID: 1658383 Free PMC article.
-
RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.Biochemistry (Mosc). 1998 May;63(5):489-503. Biochemistry (Mosc). 1998. PMID: 9632883 Review.
-
Multifaceted activities of the HIV-1 transactivator of transcription, Tat.J Biol Chem. 1999 Oct 8;274(41):28837-40. doi: 10.1074/jbc.274.41.28837. J Biol Chem. 1999. PMID: 10506122 Review. No abstract available.
Cited by
-
HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells.Retrovirology. 2014 Apr 17;11:30. doi: 10.1186/1742-4690-11-30. Retrovirology. 2014. PMID: 24742347 Free PMC article.
-
Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.J Virol. 2005 Jul;79(13):8440-53. doi: 10.1128/JVI.79.13.8440-8453.2005. J Virol. 2005. PMID: 15956588 Free PMC article.
-
A naturally occurring substitution in human immunodeficiency virus Tat increases expression of the viral genome.J Virol. 2003 Aug;77(15):8602-6. doi: 10.1128/jvi.77.15.8602-8606.2003. J Virol. 2003. PMID: 12857933 Free PMC article.
-
Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.J Virol. 2003 Jan;77(2):989-98. doi: 10.1128/jvi.77.2.989-998.2003. J Virol. 2003. PMID: 12502815 Free PMC article.
-
Properties of the surface envelope glycoprotein associated with virulence of simian-human immunodeficiency virus SHIV(SF33A) molecular clones.J Virol. 2002 Feb;76(4):1588-99. doi: 10.1128/jvi.76.4.1588-1599.2002. J Virol. 2002. PMID: 11799153 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
